Mary S. Brady

16.5k total citations
106 papers, 4.7k citations indexed

About

Mary S. Brady is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Mary S. Brady has authored 106 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 23 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Mary S. Brady's work include Cutaneous Melanoma Detection and Management (60 papers), Nonmelanoma Skin Cancer Studies (21 papers) and Melanoma and MAPK Pathways (14 papers). Mary S. Brady is often cited by papers focused on Cutaneous Melanoma Detection and Management (60 papers), Nonmelanoma Skin Cancer Studies (21 papers) and Melanoma and MAPK Pathways (14 papers). Mary S. Brady collaborates with scholars based in United States, Australia and United Kingdom. Mary S. Brady's co-authors include Daniel G. Coit, Klaus J. Busam, Katherine S. Panageas, Ami B. Patel, Paul Russo, Stuart H. Q. Quan, Dimitrios P. Mastorakos, Christian P. Pavlovich, Jeffrey P. Kavolius and Marianne Berwick and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Mary S. Brady

103 papers receiving 4.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mary S. Brady 3.5k 1.2k 1.0k 997 641 106 4.7k
Jonathan S. Zager 4.4k 1.3× 940 0.8× 1.2k 1.1× 1.9k 1.9× 534 0.8× 288 6.3k
Lori Lowe 3.4k 1.0× 464 0.4× 1.7k 1.7× 949 1.0× 478 0.7× 154 5.2k
Jochen H. Lorch 2.9k 0.8× 948 0.8× 682 0.7× 1.0k 1.0× 1.5k 2.4× 121 5.4k
Elvio G. Silva 1.9k 0.5× 1.7k 1.4× 1.4k 1.4× 1.3k 1.3× 1.9k 3.0× 157 8.2k
William H. Sharfman 4.6k 1.3× 1.3k 1.1× 626 0.6× 1.2k 1.2× 550 0.9× 82 6.1k
Steven D. Billings 1.9k 0.6× 2.1k 1.8× 408 0.4× 749 0.8× 618 1.0× 239 4.8k
C. Wayne Cruse 3.2k 0.9× 258 0.2× 1.8k 1.7× 692 0.7× 553 0.9× 105 4.3k
Jessica C. Hassel 4.6k 1.3× 889 0.8× 648 0.6× 2.2k 2.2× 287 0.4× 251 6.4k
Josette Brière 7.4k 2.2× 1.3k 1.1× 803 0.8× 1.4k 1.4× 657 1.0× 190 13.6k
Nadeem Riaz 4.6k 1.3× 2.4k 2.1× 636 0.6× 2.4k 2.4× 1.6k 2.5× 243 9.2k

Countries citing papers authored by Mary S. Brady

Since Specialization
Citations

This map shows the geographic impact of Mary S. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary S. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary S. Brady more than expected).

Fields of papers citing papers by Mary S. Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary S. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary S. Brady. The network helps show where Mary S. Brady may publish in the future.

Co-authorship network of co-authors of Mary S. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Mary S. Brady. A scholar is included among the top collaborators of Mary S. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary S. Brady. Mary S. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurtansky, Nicholas R., Emily R. Nadelmann, Andrea P. Moy, et al.. (2024). Declining Clinical Utility of Tools for Predicting Sentinel Lymph Node Biopsy Status: A Single Institution Experience from 2000 to 2021. Annals of Surgical Oncology. 32(3). 1463–1472. 2 indexed citations
2.
Bartlett, Edmund K., Ann Y. Lee, Philip M. Spanheimer, et al.. (2020). Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma. British journal of surgery. 107(11). 1480–1488. 9 indexed citations
3.
Brady, Mary S., et al.. (2020). Merkel Cell Carcinoma Of The Skin. StatPearls. 1 indexed citations
4.
Ullrich, Sarah, et al.. (2018). Parastomal hernia repair using the “top hat” technique - An initial experience in 30 patients at Memorial Sloan Kettering Cancer Center. The American Journal of Surgery. 216(3). 465–470. 7 indexed citations
5.
Sahu, Joya, et al.. (2015). Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis. Oncotarget. 6(11). 8593–8605. 16 indexed citations
6.
Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2013). Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma. Annals of Surgical Oncology. 20(9). 3106–3111. 42 indexed citations
7.
Beasley, Georgia M., A Coleman, A. Kevin Raymond, et al.. (2012). A Phase I Multi-Institutional Study of Systemic Sorafenib in Conjunction with Regional Melphalan for In-Transit Melanoma of the Extremity. Annals of Surgical Oncology. 19(12). 3896–3905. 14 indexed citations
8.
Fields, Ryan C., Klaus J. Busam, Joanne F. Chou, et al.. (2011). Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer. 118(13). 3311–3320. 73 indexed citations
9.
Shah, Gaurav, Nicholas D. Socci, Jason S. Gold, et al.. (2010). Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Annals of Oncology. 21(8). 1718–1722. 30 indexed citations
10.
Kimsey, Troy F., Tzeela Cohen, Ami B. Patel, Klaus J. Busam, & Mary S. Brady. (2009). Microscopic Satellitosis in Patients with Primary Cutaneous Melanoma: Implications for Nodal Basin Staging. Annals of Surgical Oncology. 16(5). 1176–1183. 30 indexed citations
11.
Taylor, Rebecca C., Ami B. Patel, Katherine S. Panageas, Klaus J. Busam, & Mary S. Brady. (2007). Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma. Journal of Clinical Oncology. 25(7). 869–875. 224 indexed citations
12.
Morris, Katherine T., et al.. (2007). Primary Cutaneous Melanoma with Regression Does not Require a Lower Threshold for Sentinel Lymph Node Biopsy. Annals of Surgical Oncology. 15(1). 316–322. 57 indexed citations
13.
Brady, Mary S., et al.. (2006). Streptococcal Septic Shock after Inguinal Lymphadenectomy. Surgical Infections. 7(6). 547–550. 5 indexed citations
14.
Brady, Mary S., Timothy Akhurst, Kathryn Spanknebel, et al.. (2006). Utility of Preoperative [(18)]F Fluorodeoxyglucose–Positron Emission Tomography Scanning in High-Risk Melanoma Patients. Annals of Surgical Oncology. 13(4). 525–532. 62 indexed citations
15.
Brady, Mary S., et al.. (2006). A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology. 13(8). 1123–1129. 60 indexed citations
16.
Busam, Klaus J., et al.. (2006). Cutaneous melanoma arising in a burn scar: two recent cases and a review of the literature. Melanoma Research. 16(1). 71–76. 9 indexed citations
17.
Berwick, Marianne, Yulin Song, Rick Jordan, Mary S. Brady, & Irene Orlow. (2001). Mutagen sensitivity as an indicator of soft tissue sarcoma risk. Environmental and Molecular Mutagenesis. 38(2-3). 223–226. 7 indexed citations
18.
Brady, Mary S., et al.. (1999). Cytokine production by CD4+ T-cells responding to antigen presentation by melanoma cells. Melanoma Research. 9(2). 173–180. 9 indexed citations
19.
Saenz, Nicholas C., et al.. (1999). Childhood melanoma survival. Cancer. 85(3). 750–754. 83 indexed citations
20.
Berking, Carola & Mary S. Brady. (1997). Cutaneous melanoma in patients with sarcoma. Cancer. 79(4). 843–848. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan S. Zager Breakdown of academic impact, for papers by Lori Lowe Breakdown of academic impact, for papers by Jochen H. Lorch Breakdown of academic impact, for papers by Elvio G. Silva Breakdown of academic impact, for papers by William H. Sharfman Breakdown of academic impact, for papers by Steven D. Billings Breakdown of academic impact, for papers by C. Wayne Cruse Breakdown of academic impact, for papers by Jessica C. Hassel Breakdown of academic impact, for papers by Josette Brière Breakdown of academic impact, for papers by Nadeem Riaz
Rankless by CCL
2026